By working with clients to navigate the complex world of federal regulation by the U.S. Food and Drug Administration, Anne Spiggle helps clients focus on their business objectives. Anne believes she can best enable clients to achieve their goals by taking a multi-faceted, “think-out-of-the-box” approach that considers the client’s needs from regulatory and public policy angles. She has developed a broad range of regulatory experience, representing clients in connection with the development, promotion and sale of:

  • Foods
  • Dietary supplements
  • Prescription and over-the-counter drugs
  • Cosmetics
  • Medical devices
  • Animal feed
  • Consumer products

Anne’s representation of clients includes significant experience on a wide range of regulatory and public policy matters involving the Food and Drug Administration (FDA), the Federal Trade Commission (FTC), the Consumer Product Safety Commission (CPSC) and other federal and state health and safety regulatory agencies. This experience includes:

  • Counseling clients on regulatory requirements
  • Assisting clients in responding to regulatory enforcement actions
  • Helping clients engage in the regulatory process through preparation of regulatory submissions (such as Citizen Petitions, New Dietary Ingredient submissions and comments on agency rulemakings)
  • Advising clients on product labeling, advertising, and promotion and claims substantiation, and helping clients respond to challenges to their labeling, advertising, and promotion

Anne also counsels clients on reporting adverse events and carrying out product recalls. She assists clients in conducting regulatory due diligence on corporate transactions and private equity investments. Drawing on her years of experience engaging with regulators, lawmakers, and industry, Anne can think creatively to provide clients with practical advice and fresh perspective.

Education

  • Georgetown University Law Center (J.D., cum laude, 2002)
    • Cornell University (B.A., magna cum laude, 1996)

      Bar Admission

      • District of Columbia, 2003
      • Maryland, 2002

      Professional Affiliations

      • District of Columbia Bar
      • Maryland State Bar Association
      Publications
      In-House Influence Podcast
      Welcome to In-House Influence, a podcast that features interviews with some of the nation’s most influential in-house counsel. In-House Influence is a proud partnership between Polsinelli’s Washington, D.C., Office and the Association of Corporate Counsel National Capital Region. In-House Influence features interviews on the 'how' behind each guest's path toward leadership – with a focus on their youth during the ages of 7-17. Each podcast, divided into 10-minute sections, highlights four different trailblazers in the legal community from various industries, including government contractors, health care, real estate, technology, and financial services. Guests reflect on hardships, mentorship and early life decisions that helped mold them into the leaders they are today. Since 2016, our audience has been listening and learning about different journeys
      Read More
      FDA 2023-24: A Look Back & A Peek Forward
      Introduction Most years are eventful for businesses regulated by the US Food and Drug Administration (“FDA”), and 2023 was no exception. 2024 promises more of the same – it being a Presidential election year, some FDA decisions (increased access to medications used to terminate pregnancy, to cite one obvious example) will feature prominently in the campaign. Democrats unequivocally intend to make reproductive rights a feature of President Biden’s re-election campaign. Presidential election years also tend to influence when and whether regulations (proposed and final) are issued, as the White House review of decisions by regulators gets enhanced political scrutiny, both before and after the election, particularly when there is a change in administrations. To help you navigate the coming year, the Polsinelli
      Read More